MilliporeSigma
  • Home
  • Search Results
  • The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.

The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.

Science signaling (2014-08-21)
Tai Kiuchi, Elena Ortiz-Zapater, James Monypenny, Daniel R Matthews, Lan K Nguyen, Jody Barbeau, Oana Coban, Katherine Lawler, Brian Burford, Daniel J Rolfe, Emanuele de Rinaldis, Dimitra Dafou, Michael A Simpson, Natalie Woodman, Sarah Pinder, Cheryl E Gillett, Viviane Devauges, Simon P Poland, Gilbert Fruhwirth, Pierfrancesco Marra, Ykelien L Boersma, Andreas Plückthun, William J Gullick, Yosef Yarden, George Santis, Martyn Winn, Boris N Kholodenko, Marisa L Martin-Fernandez, Peter Parker, Andrew Tutt, Simon M Ameer-Beg, Tony Ng
ABSTRACT

The epidermal growth factor receptor (EGFR) is a member of the ErbB family that can promote the migration and proliferation of breast cancer cells. Therapies that target EGFR can promote the dimerization of EGFR with other ErbB receptors, which is associated with the development of drug resistance. Understanding how interactions among ErbB receptors alter EGFR biology could provide avenues for improving cancer therapy. We found that EGFR interacted directly with the CYT1 and CYT2 variants of ErbB4 and the membrane-anchored intracellular domain (mICD). The CYT2 variant, but not the CYT1 variant, protected EGFR from ligand-induced degradation by competing with EGFR for binding to a complex containing the E3 ubiquitin ligase c-Cbl and the adaptor Grb2. Cultured breast cancer cells overexpressing both EGFR and ErbB4 CYT2 mICD exhibited increased migration. With molecular modeling, we identified residues involved in stabilizing the EGFR dimer. Mutation of these residues in the dimer interface destabilized the complex in cells and abrogated growth factor-stimulated cell migration. An exon array analysis of 155 breast tumors revealed that the relative mRNA abundance of the ErbB4 CYT2 variant was increased in ER+ HER2- breast cancer patients, suggesting that our findings could be clinically relevant. We propose a mechanism whereby competition for binding to c-Cbl in an ErbB signaling heterodimer promotes migration in response to a growth factor gradient.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-EGFR antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
Anti-EGFR antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-EGFR antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
MISSION® esiRNA, targeting human CD19
Sigma-Aldrich
Anti-EGFR antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-EGFR antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-EGFR (Ab-1110) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-EGFR (Ab-1092) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-EGFR (Ab-1172) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Monoclonal Anti-EGFR antibody produced in mouse, clone 4H2, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-Epidermal Growth Factor Receptor antibody produced in mouse, clone F4, ascites fluid
Sigma-Aldrich
Monoclonal Anti-Epidermal Growth Factor Receptor antibody produced in mouse, clone 29.1, ascites fluid
Sigma-Aldrich
Anti-EGFR (Ab-693) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-EGFR (Ab-1070) antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-EGFR (Ab-1197) antibody produced in goat, affinity isolated antibody
Sigma-Aldrich
Rabbit anti-EGFR Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
Sigma-Aldrich
Monoclonal Anti-EGFR antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0815, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Cd19
Sigma-Aldrich
Anti-Epidermal Growth Factor Receptor antibody produced in goat, affinity isolated antibody, lyophilized powder
Sigma-Aldrich
Monoclonal Anti-Epidermal Growth Factor Receptor antibody produced in mouse, clone 102618, purified immunoglobulin, lyophilized powder